Author:
Lepage Laura,Poivret Didier,Lemétayer Fabienne
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Adler, R. A., & Gill, R. S. (2011). Clinical utility of denosumab for treatment of bone loss in men and women. Clinical interventions in aging, 6, 119. https://doi.org/10.2147/CIA.S14565
2. Aikens, J. E., Wagner, L. I., Lickerman, A. J., Chin, M. H., & Smith, A. (1998). Primary care physician responses to a panic disorder vignette: Diagnostic suspicion and clinical management. The International Journal of Psychiatry in Medicine, 28(2), 179–188.https://doi.org/10.2190/3ATH-C9F4-2RTA-PXHA
3. Alami, S., Hervouet, L., Poiraudeau, S., Briot, K., & Roux, C. (2016). Barriers to effective postmenopausal osteoporosis treatment: A qualitative study of patients? and practitioners? views. PloS One, 11(6), e0158365. https://doi.org/10.1371/journal.pone.0158365
4. Belgacem, A., Nouira, A., & Soussi, S. (2016). Perceptions of tunisian women based on the health beliefs model and their practices related to osteoporosis. The Pan African Medical Journal, 23, 42–42. https://doi.org/10.11604/pamj.2016.23.42.6643
5. Berthelemy, M. (2014). Assessing the benefit/risk ratio of drugs in Europe: a case study with a multiple sclerosis treatment [Doctoral thesis, University of Lorraine].